Harvard Apparatus Regenerative Technology, Inc. financial data

Symbol
HRGN on OTC
Location
84 October Hill Road, Suite 11, Holliston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 226 % +259%
Quick Ratio 5.71 % +70%
Debt-to-equity 55.1 %
Return On Equity -271 % +63.9%
Return On Assets -175 % +16.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.2M shares +18.2%
Common Stock, Shares, Outstanding 15.9M shares +11.2%
Entity Public Float 28.3M USD -16.3%
Common Stock, Value, Issued 159K USD +11.2%
Weighted Average Number of Shares Outstanding, Basic 15.9M shares +11.6%
Weighted Average Number of Shares Outstanding, Diluted 15M shares +8.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 679K USD +466%
Cost of Revenue 302K USD +2223%
Research and Development Expense 2.13M USD -13.9%
Selling and Marketing Expense 449K USD -91.3%
General and Administrative Expense 4.45M USD -12.8%
Costs and Expenses 2.15M USD -15.3%
Operating Income (Loss) -6.73M USD +15.4%
Nonoperating Income (Expense) 10K USD
Net Income (Loss) Attributable to Parent -6.69M USD +16.1%
Earnings Per Share, Basic 0 USD/shares +29.8%
Earnings Per Share, Diluted 0 USD/shares +16.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 786K USD +465%
Cash, Cash Equivalents, and Short-term Investments 3.6M USD +140%
Accounts Receivable, after Allowance for Credit Loss, Current 5K USD
Inventory, Net 27K USD -55%
Assets, Current 1.12M USD +70.3%
Property, Plant and Equipment, Net 8K USD -42.9%
Operating Lease, Right-of-Use Asset 245K USD +260%
Other Assets, Noncurrent 62K USD -64.2%
Assets 2.14M USD -51.9%
Accounts Payable, Current 352K USD -53.2%
Employee-related Liabilities, Current 349K USD +124%
Contract with Customer, Liability, Current 149K USD
Liabilities, Current 1.23M USD -38.2%
Operating Lease, Liability, Noncurrent 145K USD +418%
Liabilities 1.38M USD -31.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7K USD +68.2%
Retained Earnings (Accumulated Deficit) -103M USD -6.93%
Stockholders' Equity Attributable to Parent 761K USD
Liabilities and Equity 2.14M USD +23.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -758K USD +21%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities -9K USD
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 15.9M shares +11.2%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -758K USD -374%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 432K USD -65.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2K USD -77.8%
Deferred Tax Assets, Valuation Allowance 26.8M USD +7.66%
Deferred Tax Assets, Gross 26.9M USD +7.93%
Operating Lease, Liability 249K USD +266%
Depreciation 2K USD -66.7%
Payments to Acquire Property, Plant, and Equipment 9K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -6.67M USD +15.7%
Lessee, Operating Lease, Liability, to be Paid 288K USD +289%
Property, Plant and Equipment, Gross 1.49M USD 0%
Operating Lease, Liability, Current 104K USD +160%
Lessee, Operating Lease, Liability, to be Paid, Year Two 90K USD +800%
Lessee, Operating Lease, Liability, to be Paid, Year One 133K USD +224%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure +61.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 39K USD +550%
Lessee, Operating Lease, Liability, to be Paid, Year Three 90K USD
Deferred Tax Assets, Operating Loss Carryforwards 20.1K USD +6.7%
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 32K USD +14.3%
Additional Paid in Capital 104M USD +8.02%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 80K USD +515%
Share-based Payment Arrangement, Expense 562K USD +5.05%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%